all pragmatic points I personally don't expect
Post# of 30028
Posted On: 09/22/2014 10:31:48 AM
all pragmatic points
I personally don't expect any great announcements whatsoever at the ASM
AMBS's overall game plan will just take a while longer - thats all
update to next 4 key 'near term' milestones:
1.) LymPro - LP-002 clinical performance data results (est. Sept.)
2.) LymPro - CLIA submission / CLIA launch (est. 4Q14)
3.) Manf - data from MANF at targeting ocular disorders (on 10/6)
4.) Eltoprazine - 200 patient Ph. 2b trial PD-LID & submission of pre-IND (est. early 4Q14)
I personally don't expect any great announcements whatsoever at the ASM
AMBS's overall game plan will just take a while longer - thats all
update to next 4 key 'near term' milestones:
1.) LymPro - LP-002 clinical performance data results (est. Sept.)
2.) LymPro - CLIA submission / CLIA launch (est. 4Q14)
3.) Manf - data from MANF at targeting ocular disorders (on 10/6)
4.) Eltoprazine - 200 patient Ph. 2b trial PD-LID & submission of pre-IND (est. early 4Q14)
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼